Amiodarone-induced thyrotoxicosis (AIT) are not uncommon endocrinopathies. Clinicians are sometimes faced with difficult diagnostic and therapeutic situations. The disease pathophysiology is partially understood, explaining the lack of predictive factors for occurrence. Different international recommendations for their management have been published: the most recent in 2018 by the European Thyroid Association (ETA) (Ross et al., 2016; Bartalena et al., 2018). The purpose of this paper is to present the essential concepts for their management and to review the literature since 2018. (C) 2020 Elsevier Masson SAS. All rights reserved.
机构:
Kantonsspital, Bereich Med 1, DIM, Abt Kardiol, CH-4031 Basel, SwitzerlandKantonsspital, Bereich Med 1, DIM, Abt Kardiol, CH-4031 Basel, Switzerland
Kaufmann, C
Cron, TA
论文数: 0引用数: 0
h-index: 0
机构:Kantonsspital, Bereich Med 1, DIM, Abt Kardiol, CH-4031 Basel, Switzerland
Cron, TA
Meier, C
论文数: 0引用数: 0
h-index: 0
机构:Kantonsspital, Bereich Med 1, DIM, Abt Kardiol, CH-4031 Basel, Switzerland
Meier, C
Staub, JJ
论文数: 0引用数: 0
h-index: 0
机构:Kantonsspital, Bereich Med 1, DIM, Abt Kardiol, CH-4031 Basel, Switzerland
Staub, JJ
Oberholzer, M
论文数: 0引用数: 0
h-index: 0
机构:Kantonsspital, Bereich Med 1, DIM, Abt Kardiol, CH-4031 Basel, Switzerland
Oberholzer, M
Osswald, S
论文数: 0引用数: 0
h-index: 0
机构:Kantonsspital, Bereich Med 1, DIM, Abt Kardiol, CH-4031 Basel, Switzerland